Vascular damage and lack of angiogenesis in systemic sclerosis skin

被引:40
作者
Konttinen, YT
Mackiewicz, Z
Ruuttila, P
Ceponis, A
Sukura, A
Povilenaite, D
Hukkanen, M
Virtanen, I
机构
[1] Biomedicum Helsinki, FIN-00029 Helsinki, Finland
[2] Orton Res Inst, Dept Med, Helsinki, Finland
[3] Invalid Fdn, Orthopaed Hosp, Helsinki, Finland
[4] Univ Helsinki, Inst Biomed Anat, FIN-00014 Helsinki, Finland
[5] Univ Opole, Dept Cell Biol, Opole, Poland
[6] RW Johnson Pharmaceut Res Inst, San Diego, CA 92121 USA
[7] Univ Helsinki, Inst Vet Med Pathol, FIN-00014 Helsinki, Finland
基金
芬兰科学院;
关键词
neovascularisation; microvessels; systemic sclerosis; von Willebrand factor;
D O I
10.1007/s10067-003-0698-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to analyse microvascular damage and compensatory angiogenesis in skin from patients with systemic sclerosis (SSc) compared with systemic lupus erythematosus (SLE), Raynaud's phenomenon (RP) and healthy controls. Immunohistochemistry was used for skin biopsies (9 SSc, 10 SLE, 9 RP and 12 healthy controls) using von Willebrand factor and beta(3) integrin subunit specific antibodies, TechMate immunostaining robot and biotin-streptavidin protocol. In the early stages of SSc, vWF was found in the perivascular space and interstitial matrix in papillary but not in the reticular dermis, in particular around small oedematous blood vessels infiltrated by mononuclear cells. The extravascular release of vWF in SSc specimens was associated with weak or even a total lack of immunoreactivity within the associated endothelial cells. Late stages of SSc were characterised by loss of the dermal papillae, subepidermal fibrosis, hypovascularity and strong endothelial vWF expression without extravascular leakage. In all SSc patients studied only a few vascular profiles were weakly immunostained for beta(3) integrin subunit. This work demonstrates that vWF is not only released into the systemic circulation, but is also leaked to the perivascular space/matrix. This local release and deposition of vWF is probably a sensitive and early marker of microvascular involvement in SSc pathogenesis. Local vWF release may play a role in platelet adhesion, aggregation, thrombogenesis and dermal connective tissue remodelling. In spite of some attempts towards compensatory angiogenesis in SSc, as evidenced by beta(3) integrin subunit expression, it was evident that the angiogenic response was not able to prevent the development of hypovascularity during the advanced stages of the disease.
引用
收藏
页码:196 / 202
页数:7
相关论文
共 46 条
[11]   [H-3] THYMIDINE LABELING OF DERMAL ENDOTHELIAL CELLS IN SCLERODERMA [J].
FLEISCHMAJER, R ;
PERLISH, JS .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1977, 69 (04) :379-382
[12]   Blood vessel formation: What is its molecular basis? [J].
Folkman, J ;
DAmore, PA .
CELL, 1996, 87 (07) :1153-1155
[13]   Rational therapy in the treatment of systemic sclerosis [J].
Furst, DE .
CURRENT OPINION IN RHEUMATOLOGY, 2000, 12 (06) :540-544
[14]   Fluid shear stress modulates von Willebrand factor release from human vascular endothelium [J].
Galbusera, M ;
Zoja, C ;
Donadelli, R ;
Paris, S ;
Morigi, M ;
Benigni, A ;
Figliuzzi, M ;
Remuzzi, G ;
Remuzzi, A .
BLOOD, 1997, 90 (04) :1558-1564
[15]   Angiogenesis: the role of the microenvironment in flipping the switch [J].
Giordano, FJ ;
Johnson, RS .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2001, 11 (01) :35-40
[16]  
Herouy Y, 2000, INT J MOL MED, V6, P515
[17]   Vascular function in systemic sclerosis [J].
Herrick, AL .
CURRENT OPINION IN RHEUMATOLOGY, 2000, 12 (06) :527-533
[18]  
Herron GS, 1998, SEMIN CUTAN MED SURG, V17, P12
[19]   INCREASED FACTOR-VIII-VONWILLEBRAND FACTOR ANTIGEN AND VONWILLEBRAND-FACTOR ACTIVITY IN SCLERODERMA AND IN RAYNAUD PHENOMENON [J].
KAHALEH, MB ;
OSBORN, I ;
LEROY, EC .
ANNALS OF INTERNAL MEDICINE, 1981, 94 (04) :482-484
[20]  
LEROY EC, 1988, J RHEUMATOL, V15, P202